{"id":"https://openalex.org/W2238336643","doi":"https://doi.org/10.1158/1538-7445.am2015-5556","title":"Abstract 5556: Enhancing response of Ganoderma lucidum (Reishi) and lapatinib in HER2+ inflammatory breast cancer cells","display_name":"Abstract 5556: Enhancing response of Ganoderma lucidum (Reishi) and lapatinib in HER2+ inflammatory breast cancer cells","publication_year":2015,"publication_date":"2015-08-01","ids":{"openalex":"https://openalex.org/W2238336643","doi":"https://doi.org/10.1158/1538-7445.am2015-5556","mag":"2238336643"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2015-5556","doi":"https://doi.org/10.1158/1538-7445.am2015-5556","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2015-5556","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083838918","display_name":"Yismeilin R. Feliz\u2010Mosquea","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185665358","display_name":"InterAmerican University of Puerto Rico","ror":"https://ror.org/00xcgnn15","country_code":"PR","type":"education","lineage":["https://openalex.org/I185665358"]}],"countries":["PR"],"is_corresponding":false,"raw_author_name":"Yismeilin Feliz-Mosquea","raw_affiliation_strings":["1Interamerican University of Puerto Rico, Bayamon, PR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Interamerican University of Puerto Rico, Bayamon, PR;","institution_ids":["https://openalex.org/I185665358"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041702093","display_name":"Ivette J. Su\u00e1rez-Arroyo","orcid":"https://orcid.org/0000-0002-5252-9227","observed_orcids":["https://orcid.org/0000-0002-5252-9227"]},"institutions":[{"id":"https://openalex.org/I201879955","display_name":"Central University of the Caribbean","ror":"https://ror.org/01rpmzy83","country_code":"PR","type":"education","lineage":["https://openalex.org/I201879955"]}],"countries":["PR"],"is_corresponding":false,"raw_author_name":"Ivette Suarez-Arroyo","raw_affiliation_strings":["2Universidad Central del Caribe-School of Medicine, Bayamon, PR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Universidad Central del Caribe-School of Medicine, Bayamon, PR","institution_ids":["https://openalex.org/I201879955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041569999","display_name":"Yaliz Loperena-\u00c1lvarez","orcid":"https://orcid.org/0000-0002-9629-1169","observed_orcids":["https://orcid.org/0000-0002-9629-1169"]},"institutions":[{"id":"https://openalex.org/I201879955","display_name":"Central University of the Caribbean","ror":"https://ror.org/01rpmzy83","country_code":"PR","type":"education","lineage":["https://openalex.org/I201879955"]}],"countries":["PR"],"is_corresponding":false,"raw_author_name":"Yaliz Loperena","raw_affiliation_strings":["2Universidad Central del Caribe-School of Medicine, Bayamon, PR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Universidad Central del Caribe-School of Medicine, Bayamon, PR","institution_ids":["https://openalex.org/I201879955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066604159","display_name":"Luis A. Cubano","orcid":"https://orcid.org/0000-0002-6608-0336","observed_orcids":["https://orcid.org/0000-0002-6608-0336"]},"institutions":[{"id":"https://openalex.org/I201879955","display_name":"Central University of the Caribbean","ror":"https://ror.org/01rpmzy83","country_code":"PR","type":"education","lineage":["https://openalex.org/I201879955"]}],"countries":["PR"],"is_corresponding":false,"raw_author_name":"Luis A. Cubano","raw_affiliation_strings":["2Universidad Central del Caribe-School of Medicine, Bayamon, PR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Universidad Central del Caribe-School of Medicine, Bayamon, PR","institution_ids":["https://openalex.org/I201879955"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063113479","display_name":"Michelle Mart\u00ednez","orcid":"https://orcid.org/0000-0002-6933-9905","observed_orcids":["https://orcid.org/0000-0002-6933-9905"]},"institutions":[{"id":"https://openalex.org/I201879955","display_name":"Central University of the Caribbean","ror":"https://ror.org/01rpmzy83","country_code":"PR","type":"education","lineage":["https://openalex.org/I201879955"]}],"countries":["PR"],"is_corresponding":false,"raw_author_name":"Michelle M. Martinez-Montemayor","raw_affiliation_strings":["2Universidad Central del Caribe-School of Medicine, Bayamon, PR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Universidad Central del Caribe-School of Medicine, Bayamon, PR","institution_ids":["https://openalex.org/I201879955"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"75","issue":"15_Supplement","first_page":"5556","last_page":"5556"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11085","display_name":"Fungal Biology and Applications","score":0.4821999967098236,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11085","display_name":"Fungal Biology and Applications","score":0.4821999967098236,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0649000033736229,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12087","display_name":"Natural Compound Pharmacology Studies","score":0.03700000047683716,"subfield":{"id":"https://openalex.org/subfields/1110","display_name":"Plant Science"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ganoderma-lucidum","display_name":"Ganoderma lucidum","score":0.9490000009536743},{"id":"https://openalex.org/keywords/reishi-mushroom","display_name":"reishi mushroom","score":0.8600000143051147},{"id":"https://openalex.org/keywords/lapatinib","display_name":"lapatinib","score":0.9390000104904175},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9070000052452087},{"id":"https://openalex.org/keywords/inflammatory-breast-cancer","display_name":"inflammatory breast cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7319999933242798},{"id":"https://openalex.org/keywords/her2-downregulation","display_name":"HER2 downregulation","score":0.7139999866485596},{"id":"https://openalex.org/keywords/cell-viability","display_name":"cell viability","score":0.7820000052452087},{"id":"https://openalex.org/keywords/anticancer-natural-products","display_name":"anticancer natural products","score":0.675000011920929},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.6579999923706055},{"id":"https://openalex.org/keywords/molecular-subtypes-of-breast-cancer","display_name":"molecular subtypes of breast cancer","score":0.7310000061988831},{"id":"https://openalex.org/keywords/epidermal-growth-factor-receptor-2","display_name":"epidermal growth factor receptor 2","score":0.7820000052452087}],"concepts":[{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.93064284324646},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.6632227897644043},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6071667075157166},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.4787292182445526},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4528277516365051},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4509550631046295},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.44763052463531494},{"id":"https://openalex.org/C2780839634","wikidata":"https://www.wikidata.org/wiki/Q5922406","display_name":"Inflammatory breast cancer","level":4,"score":0.44692301750183105},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.4348001480102539},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33878859877586365},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.33368533849716187},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3008244037628174},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.16867685317993164},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.15703696012496948},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2015-5556","doi":"https://doi.org/10.1158/1538-7445.am2015-5556","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2015-5556","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2020263433","https://openalex.org/W2020598712","https://openalex.org/W2148594349","https://openalex.org/W2087093411","https://openalex.org/W2009497954","https://openalex.org/W2338553816","https://openalex.org/W1580577401","https://openalex.org/W2340485139","https://openalex.org/W2026898449","https://openalex.org/W2978268548"],"abstract_inverted_index":{"Abstract":[0],"Inflammatory":[1],"Breast":[2],"Cancer":[3,368,378],"(IBC)":[4],"is":[5,22,47,74,172],"an":[6,50],"aggressive":[7],"and":[8,26,59,70,131,144,179,186,196,261,347],"unique":[9],"form":[10],"of":[11,31,52,102,112,134,151,204,214,221,231,234,247,272,287,308,343,358,363],"breast":[12,20,35,352],"cancer":[13,36,176,281,353],"that":[14,46,95,173,278],"develops":[15],"rapidly.":[16],"IBC,":[17],"like":[18],"non-IBC":[19],"cancers,":[21],"a":[23,85,229,242,290],"heterogeneous":[24],"disease":[25],"can":[27],"occur":[28],"as":[29,289],"any":[30],"the":[32,60,100,103,129,135,149,161,264,285,359,364],"six":[33],"molecular":[34,132],"subtypes.":[37],"However,":[38],"they":[39],"are":[40],"most":[41],"commonly":[42],"either":[43],"triple":[44,104],"negative;":[45],"presenting":[48],"with":[49,160,201,228,253],"absence":[51],"estrogen":[53],"receptor":[54,57,64],"(ER-),":[55],"progesterone":[56],"(PR-)":[58],"epidermal":[61],"growth":[62],"factor":[63],"2":[65],"(HER2-)":[66],"or":[67,210],"ER-,":[68,136],"PR-":[69],"HER2+":[71,138,350],"overexpressed.":[72],"There":[73],"no":[75],"specific":[76],"IBC":[77,106,139,154,181],"treatment;":[78],"thus,":[79],"it":[80],"seems":[81],"possible":[82],"to":[83,124,183,224,301,311,316,321],"find":[84],"therapeutic":[86],"for":[87,169,208,236,257,367],"this":[88,120,170],"deadly":[89],"disease.":[90],"Our":[91,274],"published":[92],"data":[93,240],"demonstrates":[94],"Ganoderma":[96,344],"lucidum":[97,345],"(Reishi)":[98,346],"inhibits":[99,175,280],"viability":[101,130,178,220,246],"negative":[105],"SUM149":[107],"cell":[108,140,177,219,245,269,282],"line,":[109],"but":[110],"not":[111],"MCF10A":[113],"noncancerous":[114],"mammary":[115],"epithelial":[116],"cells.":[117,354],"Subsequently,":[118],"in":[119,128,158,191,244,249,267,349],"study,":[121],"we":[122,147],"aimed":[123],"investigate":[125],"Reishi":[126,152,174,207,217,235,256,260,279,288],"effects":[127,150],"signaling":[133],"PR-,":[137],"lines":[141],"SUM190,":[142,194],"KPL-4":[143,195,222,268],"IBC-3.":[145],"Furthermore,":[146],"studied":[148],"on":[153],"cells":[155,182,198,223,251],"when":[156,226],"treated":[157,200,227,252],"complement":[159],"HER2":[162,266],"Tyrosine":[163],"Kinase":[164],"Inhibitor,":[165],"lapatinib.":[166],"The":[167,212],"hypothesis":[168],"study":[171],"sensitizes":[180],"lapatinib":[184,205,215,254,262,348],"therapy":[185],"downregulates":[187],"key":[188],"proteins":[189],"overexpressed":[190],"IBC.":[192],"Herein,":[193],"IBC-3":[197],"were":[199],"increasing":[202],"concentrations":[203],"and/or":[206],"24":[209],"72h.":[211,237,258],"combination":[213],"plus":[216,255],"reduced":[218],"80%":[225],"concentration":[230],"0.25":[232],"mg/mL":[233],"Additionally,":[238],"our":[239],"shows":[241],"reduction":[243],"70%":[248],"SUM190":[250],"Also,":[259],"downregulate":[263],"expression":[265],"after":[270],"72h":[271],"treatment.":[273],"results":[275],"provide":[276],"evidence":[277],"viability,":[283],"highlighting":[284],"potential":[286],"natural":[291],"anti-IBC-therapeutic.":[292],"This":[293],"project":[294],"was":[295],"sponsored":[296],"by":[297],"NIH/NCI":[298],"#1F31":[299],"CA174307":[300],"ISA,":[302],"Title":[303],"V":[304],"PPOHA":[305],"US":[306],"Department":[307],"Education":[309],"#P031M105050":[310],"UCC/LAC,":[312],"NIH/RCMI":[313],"#G12":[314],"MD007583":[315],"UCC/MMM,":[317],"NIH/INBRE":[318],"#5P20":[319],"GM103475":[320],"UPR/UCC/MMM,":[322],"NIH/NIMHD":[323],"U54":[324],"MD008149":[325],"UH/MMM.":[326],"Citation":[327],"Format:":[328],"Yismeilin":[329],"Feliz-Mosquea,":[330],"Ivette":[331],"Suarez-Arroyo,":[332],"Yaliz":[333],"Loperena,":[334],"Luis":[335],"A.":[336],"Cubano,":[337],"Michelle":[338],"M.":[339],"Martinez-Montemayor.":[340],"Enhancing":[341],"response":[342],"inflammatory":[351],"[abstract].":[355],"In:":[356],"Proceedings":[357],"106th":[360],"Annual":[361],"Meeting":[362],"American":[365],"Association":[366],"Research;":[369],"2015":[370],"Apr":[371],"18-22;":[372],"Philadelphia,":[373],"PA.":[374],"Philadelphia":[375],"(PA):":[376],"AACR;":[377],"Res":[379],"2015;75(15":[380],"Suppl):Abstract":[381],"nr":[382],"5556.":[383],"doi:10.1158/1538-7445.AM2015-5556":[384]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}